1
|
Emirzeoglu L, Arici S, Sahin AB, Ocak B, Ak N, Ay S, Mammadov E, Turna H, Bilici A. The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. Breast Care (Basel) 2023; 18:42-48. [PMID: 36876171 PMCID: PMC9982353 DOI: 10.1159/000526732] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Accepted: 08/18/2022] [Indexed: 11/19/2022] Open
Abstract
Purpose The aim of the study was to investigate the effects of body mass index (BMI) on the response to neoadjuvant chemotherapy (NACT) in Turkish patients with local and locally advanced breast cancer. Methods The pathological responses for the breast and axilla were assessed according to the Miller-Payne grading (MPG) system. Tumors were grouped into molecular phenotypes and classified as response rates according to the MPG system after the completion of NACT. A 90% or greater reduction in tumor cellularity was considered a good response to treatment. Additionally, patients were grouped according to BMI into <25 (group A) and ≥25 (group B). Results In total, 647 Turkish women with breast cancer were included in the study. In the univariate analysis, age, menopause status, tumor diameter, stage, histological grade, Ki-67, estrogen receptor (ER) status, progesterone receptor (PR) status, human epidermal growth factor receptor 2 (HER2) status, and BMI were assessed to determine which of these factors were associated with a ≥90% response rate. Stage, HER2 positivity, triple-negative breast cancer (TNBC; ER-negative, PR-negative, and HER2-negative breast cancer), grade, Ki-67 levels, and BMI were found to be the statistically significant factors for a ≥90% response rate. In the multivariate analysis, grade III disease, HER2 positivity, and TNBC were found to be the factors associated with a high pathological response. Meanwhile, hormone receptor (HR) positivity and a higher BMI were associated with a decreased pathological response in patients receiving NACT for breast cancer. Conclusion Our results show that a high BMI and HR positivity are associated with a poor response to NACT in Turkish patients with breast cancer. The findings presented in this study may guide novel studies to examine the NACT response in obese patients with and without insulin resistance.
Collapse
Affiliation(s)
- Levent Emirzeoglu
- Department of Medical Oncology, University of Health Sciences, Sultan II. Abdulhamid Han Educational and Research Hospital, Istanbul, Turkey
| | - Serdar Arici
- Department of Medical Oncology, University of Health Sciences, Sultan II. Abdulhamid Han Educational and Research Hospital, Istanbul, Turkey
| | - Ahmet Bilgehan Sahin
- Department of Medical Oncology, Faculity of Medicine, Bursa Uludag University, Bursa, Turkey
| | - Birol Ocak
- Department of Medical Oncology, Faculity of Medicine, Bursa Uludag University, Bursa, Turkey
| | - Naziye Ak
- Department of Medical Oncology, Institute of Oncology, Faculity of Medicine, Istanbul University, Istanbul, Turkey
| | - Seval Ay
- Department of Medical Oncology, Faculity of Medicine, Medeniyet University, Istanbul, Turkey
| | - Elkhan Mammadov
- Department of Medical Oncology, Faculity of Medicine, Medipol University, Istanbul, Turkey
| | - Hande Turna
- Department of Medical Oncology, Cerrahpasa Medicine Faculity, Istanbul University, Istanbul, Turkey
| | - Ahmet Bilici
- Department of Medical Oncology, Faculity of Medicine, Medipol University, Istanbul, Turkey
| |
Collapse
|
2
|
Emirzeoglu L, Olmez O, Mustafayev F, Berber U, Yilmaz I, Celik S, Oven B, Ozgun M. Prognostic value of expression levels of miR‑148a, miR‑152 and HLA‑G in colon cancer. Oncol Lett 2022; 24:226. [PMID: 35720471 PMCID: PMC9185158 DOI: 10.3892/ol.2022.13347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Accepted: 04/26/2022] [Indexed: 11/05/2022] Open
Affiliation(s)
- Levent Emirzeoglu
- Department of Medical Oncology, University of Health Sciences, Sultan II. Abdulhamid Khan Educational and Research Hospital, 34660 Istanbul, Turkey
| | - Ozgur Olmez
- Department of Medical Oncology, University of Health Sciences, Sultan II. Abdulhamid Khan Educational and Research Hospital, 34660 Istanbul, Turkey
| | - Fatma Mustafayev
- Department of Medical Oncology, University of Health Sciences, Sultan II. Abdulhamid Khan Educational and Research Hospital, 34660 Istanbul, Turkey
| | - Ufuk Berber
- Department of Pathology, University of Health Sciences, Sultan II. Abdulhamid Khan Educational and Research Hospital, 34660 Istanbul, Turkey
| | - Ismail Yilmaz
- Department of Pathology, University of Health Sciences, Sultan II. Abdulhamid Khan Educational and Research Hospital, 34660 Istanbul, Turkey
| | - Serkan Celik
- Department of Medical Oncology, Yeditepe University Koşuyolu Hospital, 34718 Istanbul, Turkey
| | - Bala Oven
- Department of Medical Oncology, Yeditepe University Koşuyolu Hospital, 34718 Istanbul, Turkey
| | - Mehmet Ozgun
- Department of Medical Oncology, University of Health Sciences, Sultan II. Abdulhamid Khan Educational and Research Hospital, 34660 Istanbul, Turkey
| |
Collapse
|
3
|
Çelik S, Öven BB, Demir MK, Yılmaz EÇ, Kanan D, Özdamarlar U, Emirzeoglu L, Yapıcıer Ö, Kılıç T. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma. Clin Neurol Neurosurg 2021; 207:106745. [PMID: 34146841 DOI: 10.1016/j.clineuro.2021.106745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2021] [Revised: 06/03/2021] [Accepted: 06/03/2021] [Indexed: 10/21/2022]
Abstract
BACKGROUND IDH mutation status is an important prognostic marker for glial tumors, which is detected immunohistochemically after surgery. Since this method is invasive, easy and noninvasive magnetic resonance imaging (MRI) methods have recently been used in predicting the IDH mutation status. However, there is currently no standard MRI technique to predict IDH mutation. We analyzed the value of conventional MRI to predict IDH mutation and its effect on survival among grade II-III astrocytoma and oligodendroglioma patients. MATERIAL AND METHODS We included WHO grade II-III astrocytoma and oligodendroglioma patients who underwent surgery at Bahcesehir University Goztepe Medical Park Hospital. All patients were analyzed according to their immunohistochemical IDH mutation status. Preoperative conventional MRI studies with respect to their location, diffusion restriction, contrast enhancement, calcification and hemorrhage on susceptibility-weighted image (SWI) or T2*- weighted imaging (T2*WI), and T2 -FLAIR mismatch properties were retrospectively assessed by a neuroradiologist. The relation between MRI characteristics and IDH mutation was analyzed using a chi-square test. The sensitivity and specificity of radiological IDH mutation were determined by ROC analysis. The impact of IDH mutation on survival was also analyzed by Kaplan-Meier tests. RESULTS IDH mutation was found to be positive in 82.5% of tumors histopathologically and 54.4% radiologically. The sensitivity and specificity were 63.8% and 90%, respectively (Area under the curve/AUC = 0.369, p = 0.08). IDH wild gliomas were predominantly diffusion-restricted tumors. IDH mutant tumors were less likely to have contrast enhancement and had lower grades compared to the IDH wild tumors. The median survival time could not be reached and the overall survival was not related to any tumor characteristics or IDH mutation. CONCLUSIONS Conventional MRI predicts IDH-mutation status in Grade II-III astrocytoma and oligodendroglioma. Contrast-enhancement and restricted diffusion were strongly associated with grade III astrocytoma and oligodendroglioma, IDH-wild type. Location, T2-FLAIR mismatch, and SWI did not contribute to making a decision on the IDH mutation status. There was no significant difference between the survival times of patients and their IDH status.
Collapse
Affiliation(s)
- Serkan Çelik
- Department of Medical Oncology, Bahcesehir University School of Medicine, Istanbul, Turkey.
| | - Bala Başak Öven
- Department of Medical Oncology, Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Mustafa Kemal Demir
- Department of Radiology, Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Enis Çağatay Yılmaz
- Department of Radiology, Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Duaa Kanan
- Department of Medical Oncology, Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Umut Özdamarlar
- Department of Radiology, Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Levent Emirzeoglu
- Department of Medical Oncology, Sultan Abdulhamid Han Training Hospital, Istanbul, Turkey
| | - Özlem Yapıcıer
- Department of Pathology, Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Türker Kılıç
- Department of Neurosurgery, Bahcesehir University School of Medicine, Istanbul, Turkey
| |
Collapse
|
4
|
Tanoglu A, Balta AZ, Berber U, Ozdemir Y, Emirzeoglu L, Sayilir A, Sucullu I. MicroRNA expression profile in patients with stage II colorectal cancer: a Turkish referral center study. Asian Pac J Cancer Prev 2016; 16:1851-5. [PMID: 25773836 DOI: 10.7314/apjcp.2015.16.5.1851] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND There are increasing data about microRNAs (miRNA) in the literature, providing abundant evidence that they play important roles in pathogenesis and development of colorectal cancer. In this study, we aimed to investigate the miRNA expression profiles in surgically resected specimens of patients with recurrent and non-recurrent colorectal cancer. MATERIALS AND METHODS The study population included 40 patients with stage II colorectal cancer (20 patients with recurrent tumors, and 20 sex and age matched patients without recurrence), who underwent curative colectomy between 2004 and 2011 without adjuvant therapy. Expression of 16 miRNAs (miRNA-9, 21, 30d, 31, 106a, 127, 133a, 133b, 135b, 143, 145, 155, 182, 200a, 200c, 362) was verified by quantitative real-time polymerase chain reaction (qRT-PCR) in all resected colon cancer tissue samples and in corresponding normal colonic tissues. Data analyses were carried out using SPSS 15 software. Values were statistically significantly changed in 40 cancer tissues when compared to the corresponding 40 normal colonic tissues (p<0.001). MiR-30d, miR-133a, miR-143, miR-145 and miR-362 expression was statistically significantly downregulated in 40 resected colorectal cancer tissue samples (p<0.001). When we compared subgroups, miRNA expression profiles of 20 recurrent cancer tissues were similar to all 40 cancer tissues. However in 20 non-recurrent cancer tissues, miR-133a expression was not significantly downregulated, moreover miR-133b expression was significantly upregulated (p<0.05). CONCLUSIONS Our study revealed dysregulation of expression of ten miRNAs in Turkish colon cancer patients. These miRNAs may be used as potential biomarkers for early detection, screening and surveillance of colorectal cancer, with functional effects on tumor cell behavior.
Collapse
Affiliation(s)
- Alpaslan Tanoglu
- Gastroenterology Department, GATA Haydarpasa Training Hospital, Uskudar-Istanbul, Turkey E-mail :
| | | | | | | | | | | | | |
Collapse
|
5
|
Celik S, Tuncel T, Emirzeoglu L, Berber U, Ozgun A, Bilgi O, Karagoz B. 100P Prognostic significance of miR-16 in triple negative breast cancer. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv519.49] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
6
|
Emirzeoglu L, Karagoz B, Berber U, Tanoglu A, Celik S, Ozgun A, Bilgi O. HLA-G expression and miR-148a, miR-152 in colorectal adenocarcinoma. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e22098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Levent Emirzeoglu
- GATA Haydarpasa Training Hospital Dpt of Medical Oncology, Istanbul, Turkey
| | - Bulent Karagoz
- GATA Haydarpasa Training Hospital Dpt of Medical Oncology, Istanbul, Turkey
| | - Ufuk Berber
- Corlu Military Hospital Dpt of Patology, Tekirdag, Turkey
| | - Alpaslan Tanoglu
- GATA Haydarpasa Training Hospital Dpt of Gastroenterology, Istanbul, Turkey
| | - Serkan Celik
- GATA Haydarpasa Training Hospital Dpt of Medical Oncology, Istanbul, Turkey
| | - Alpaslan Ozgun
- GATA Haydarpasa Training Hospital Dpt of Medical Oncology, Istanbul, Turkey
| | - Oguz Bilgi
- GATA Haydarpasa Training Hospital Dpt of Medical Oncology, Istanbul, Turkey
| |
Collapse
|
7
|
Ozgun A, Tuncel T, Emirzeoglu L, Celik S, Bilgi O, Haholu A, Urhan M, Karagoz B. Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report. Oncol Lett 2014; 9:468-470. [PMID: 25436010 PMCID: PMC4246823 DOI: 10.3892/ol.2014.2642] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2014] [Accepted: 09/22/2014] [Indexed: 11/28/2022] Open
Abstract
Malignant melanoma can be successfully treated when it is identified in its early stages, but the disease is associated with a poor prognosis when it is detected in an advanced stage. Papillary thyroid carcinoma is a thyroid cancer that has a good prognosis. The present study reports a rare case of malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously. The present patient was a 37-year-old male, in whom examination of a skin biopsy that was obtained from a lesion in the right retroauricular region revealed the lesion to be consistent with malignant melanoma. The patient underwent radical neck dissection upon the detection of malignant melanoma metastasis to the sentinel lymph node. Metastases of papillary thyroid carcinoma were detected in four out of 38 lymph nodes. The patient was then diagnosed with papillary thyroid carcinoma and underwent total thyroidectomy. The patient was administered with high-dose followed by moderate-dose interferon-α therapy for the treatment of malignant melanoma. The patient also received concurrent radioactive iodine therapy for the treatment of papillary thyroid carcinoma, at the same time as the interferon therapy. The two primary tumors of the patient were treated successfully. During therapy, no serious side-effects were observed, with the exception of fever caused by high-dose interferon therapy. Malignant melanoma and papillary thyroid carcinoma may occur concurrently, although this is rarely observed. The present study reports a rare case that demonstrates that the two tumors can be successfully treated simultaneously.
Collapse
Affiliation(s)
- Alpaslan Ozgun
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Tolga Tuncel
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Levent Emirzeoglu
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Serkan Celik
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Oguz Bilgi
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Abdullah Haholu
- Department of Pathology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Muammer Urhan
- Department of Nuclear Medicine, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Bulent Karagoz
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| |
Collapse
|
8
|
Ozgun A, Karagoz B, Tuncel T, Emirzeoglu L, Celik S, Bilgi O. Clinicopathological features and survival of young Turkish patients with testicular germ cell tumors. Asian Pac J Cancer Prev 2014; 14:6889-92. [PMID: 24377621 DOI: 10.7314/apjcp.2013.14.11.6889] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Testicular germ cell tumors (TGCTs) are a relatively common malignancy in young men. The aim of this study was to investigate the clinicopathological features and survival of young Turkish patients with TGCT. MATERIALS AND METHODS In this retrospective study, the clinical and pathological characteristics of young Turkish patients with TGCT who were monitored by the Department of Medical Oncology of a military hospital between 2008 and 2013 were investigated. Overall survival data were analyzed. RESULTS Ninety-six patients were included in the study. The mean age was 26.4 years. Among the patients, 17.7% had seminoma and 43.8% had mixed non-seminomatous germ cell tumors. Some 46.9% were Stage I, 30.2% were Stage II, and 22.9 were Stage III. Of the patients, 83.3% received chemotherapy, 25% underwent retroperitoneal lymph node dissection (RPLND), 3.1% received radiotherapy, and 12.5% were followed-up without treatment. In addition, 18.8% of the patients were administered salvage chemotherapy due to relapse or progression. The 5-year overall survival rate was 90.2% for all patients. The 2-year overall survival rate was 100% for Stage I patients, 94% for Stage II patients, and 70.2% for Stage III patients. The difference between the survival curves of stages was statistically significant (p=0.029). CONCLUSIONS In young Turkish patients with TGCT, good results were obtained with appropriate treatment, most receiving chemotherapy. The prognosis of the disease was good even in the advanced stage.
Collapse
Affiliation(s)
- Alpaslan Ozgun
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey E-mail :
| | | | | | | | | | | |
Collapse
|
9
|
Tunce T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B. Mean Platelet Volume as a Prognostic Marker in Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Combined Chemotherapy. Asian Pac J Cancer Prev 2014; 15:6421-3. [DOI: 10.7314/apjcp.2014.15.15.6421] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
10
|
Ozgun A, Tuncel T, Emirzeoglu L, Haholu A. Basal cell adenocarcinoma of the parotid gland detected in a patient with breast cancer. BMJ Case Rep 2014; 2014:bcr-2014-203791. [PMID: 24925533 DOI: 10.1136/bcr-2014-203791] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Basal cell adenocarcinoma (BCAC) is a rare tumour of the salivary glands and often associated with a good prognosis. The present case had BCAC of the parotid gland as the second primary tumour in addition to breast cancer. The patient was a 66-year-old woman who underwent mastectomy due to breast cancer. She then underwent adjuvant chemotherapy and adjuvant hormone therapy. After 4 years of disease-free follow-up, the patient presented with a swelling on the left cheek. The examination of the biopsy specimen revealed BCAC of the parotid gland. The patient then underwent left parathyroidectomy plus left neck dissection. Adjuvant radiotherapy was performed. Despite the therapy, the patient developed four local recurrences within 1 year, and then developed metastasis to the pleura. A swelling in the parotid gland in a patient with breast cancer should be carefully screened for the presence of a second primary tumour.
Collapse
Affiliation(s)
- Alpaslan Ozgun
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Tolga Tuncel
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Levent Emirzeoglu
- Department of Medical Oncology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| | - Abdullah Haholu
- Department of Pathology, Gulhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey
| |
Collapse
|
11
|
Karagoz B, Haholu A, Ozgun A, Bilgi O, Tuncel T, Emirzeoglu L, Celik S, Demirel D. HLA-G in testis germ cell tumors. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.e15620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Bulent Karagoz
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey
| | - Abdullah Haholu
- Department of Pathology Gulhane Military Medical Academia Haydarpasa Training Hospital, Istanbul, Turkey
| | - Alpaslan Ozgun
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey
| | - Oguz Bilgi
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey
| | - Tolga Tuncel
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey
| | - Levent Emirzeoglu
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey
| | - Serkan Celik
- Department of Medical Oncology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey
| | - Dilaver Demirel
- Department of Pathology Gulhane Military Medical Academia Haydarpasa Training Hospital, Istanbul, Turkey
| |
Collapse
|
12
|
Karagöz B, Haholu A, Özgün A, Bilgi O, Tunçel T, Emirzeoglu L, Çelik S, Demirel D. HLA-G in Testicular Germ Cell Tumors. Oncol Res Treat 2014; 37:245-8. [DOI: 10.1159/000362377] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2014] [Accepted: 03/13/2014] [Indexed: 11/19/2022]
|
13
|
Tuncel T, Karagoz B, Haholu A, Ozgun A, Emirzeoglu L, Bilgi O, Kandemir EG. Immunoregulatory Function of HLA-G in Gastric Cancer. Asian Pac J Cancer Prev 2013; 14:7681-4. [DOI: 10.7314/apjcp.2013.14.12.7681] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
14
|
Demirel D, Karagoz B, Berber U, Yılmaz I, Bilgi O, Haholu A, Tuncel T, Ozgun A, Balta A, Emirzeoglu L. Kras Mutations and Histopatologic Characteristics of Turkish Young Colorectal Cancer Patients. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt203.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Ozgun A, Tuncel T, Emirzeoglu L, Bilgi O, Karagoz B. Epidemiological characteristics of patients who died of cancer in the Haydarpasa Training Hospital, Istanbul. Croat Med J 2013; 53:645. [PMID: 23275334 PMCID: PMC3541596 DOI: 10.3325/cmj.2012.53.645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|